GFG Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05K | Buy |
+2
| New | +$1.05K | ﹤0.01% | 350 |
|
|
2022
Q1 | – | Sell |
-595
| Closed | -$376K | – | 164 |
|
|
2021
Q4 | $376K | Buy |
595
+32
| +6% | +$20.2K | 0.11% | 95 |
|
|
2021
Q3 | $341K | Buy |
563
+7
| +1% | +$4.24K | 0.11% | 89 |
|
|
2021
Q2 | $311K | Buy |
556
+10
| +2% | +$5.59K | 0.09% | 94 |
|
|
2021
Q1 | $258K | Sell |
546
-580
| -52% | -$274K | 0.09% | 94 |
|
|
2020
Q4 | $544K | Buy |
1,126
+21
| +2% | +$10.1K | 0.18% | 69 |
|
|
2020
Q3 | $619K | Sell |
1,105
-8
| -0.7% | -$4.48K | 0.24% | 58 |
|
|
2020
Q2 | $694K | Buy |
1,113
+38
| +4% | +$23.7K | 0.3% | 49 |
|
|
2020
Q1 | $525K | Buy |
1,075
+8
| +0.7% | +$3.91K | 0.27% | 45 |
|
|
2019
Q4 | $401K | Buy |
+1,067
| New | +$401K | 0.17% | 56 |
|